why choose us

First received: February 05, 2024

Clinical Trial: An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Contrast Enhancement in Magnetic Resonance Imaging

Study Type: OBSERVATIONAL


Official Title: Active Surveillance of the Safety of Gadolinium-based Contrast Agent(s) in India

Brief Summary: This is an observational study in which data from patients undergoing enhanced MRI using gadolinium based agents (GBCAs) are collected and studied.An MRI is a test that uses strong magnets and radio waves to make detailed pictures of the inside of the body.The contrast agents commonly used in MRI are gadolinium based contrast agents (GBCAs).GBCAs contain a "rare earth" element called gadolinium (Gd), which helps to increase the signal intensity and contrast in MRI.GBCAs have been used worldwide for MRI…

Read more